ST.
PAUL, Minn., May 31, 2023
/PRNewswire/ -- Applying its leadership in biopharma filtration
technology, 3M (NYSE: MMM) today
announced it will invest $146 million
dollars to expand its capabilities to further support
biotech manufacturing, a fast-growing area of health care which is
bringing breakthrough therapies to patients.
The investment will include facility and equipment improvements
and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
The new investment will accelerate 3M's development and delivery
of vital filtration equipment designed for bioprocessing,
biological and small molecule pharmaceutical manufacturing
applications, which will enable biotech customers to continue to
innovate therapies used for the treatment of conditions such as
rheumatoid arthritis, multiple sclerosis, and certain cancers.
Filtration and purification is essential in manufacturing
biopharmaceutical drugs. The process uses a unique filter material
that captures impurities while allowing the necessary drug
substances to pass through.
"Our investment further demonstrates 3M's continued market
leadership and ongoing commitment to customer-centric innovation in
health care," said Robert Befidi, President, 3M Separation and Purification Sciences Division.
"Our technologies improve the lives of people all over the world,
and we are helping biotech customers do more, faster, to advance
their specialized medicines."
3M offers the most comprehensive
portfolio of depth filters for cell culture clarification in the
biopharmaceutical industry. Zeta Plus™ depth filtration technology,
in cartridge systems and sheets, play an important role in the
clarification of cell-derived protein therapeutic products around
the world.
About 3M
3M (NYSE: MMM) believes science helps create a
brighter world for everyone. By unlocking the power of people,
ideas and science to reimagine what's possible, our
global team uniquely addresses the opportunities and
challenges of our customers, communities, and planet. Learn
how we're working to improve lives and make what's
next at 3M.com/news or
on Twitter at @3M or @3MNews.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/3m-to-invest-nearly-150-million-to-advance-capabilities-in-biopharma-filtration-technology-301837484.html
SOURCE 3M